These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38628789)

  • 21. Novel Cyanopyridine Compounds as KHK Inhibitors for Treating NAFLD, NASH, and Type II Diabetes.
    Sabnis RW
    ACS Med Chem Lett; 2024 Aug; 15(8):1191-1192. PubMed ID: 39140057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Compounds as NLRP3 Inhibitors for Treating Alzheimer's Disease and Parkinson's Disease.
    Sabnis RW
    ACS Med Chem Lett; 2024 Aug; 15(8):1203-1204. PubMed ID: 39140054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel PCSK9 Inhibitors for Treating Cardiovascular Diseases.
    Sabnis RW
    ACS Med Chem Lett; 2024 Apr; 15(4):443-444. PubMed ID: 38628783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel HSD17B13 Inhibitors for Treating Liver Diseases.
    Sabnis RW
    ACS Med Chem Lett; 2024 Jun; 15(6):771-772. PubMed ID: 38894932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Heterocyclic PAD4 Inhibitors for Treating Diseases.
    Sabnis RW
    ACS Med Chem Lett; 2024 Mar; 15(3):340-341. PubMed ID: 38505857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Heterocyclic PAD4 Inhibitors for Treating Multiple Diseases.
    Sabnis RW
    ACS Med Chem Lett; 2024 Feb; 15(2):179-180. PubMed ID: 38352837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel Lactams as Cbl-b Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2022 Oct; 13(10):1556-1557. PubMed ID: 36267136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Exatecan-Derived Topoisomerase-1 Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2024 May; 15(5):579-580. PubMed ID: 38746899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Lactams as CBL-B Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 Jul; 14(7):897-898. PubMed ID: 37465298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Diaminopyrimidine Carboxamides as HPK1 Inhibitors for Treating Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2023 Jul; 14(7):899-900. PubMed ID: 37465291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitrogen-Containing 2,3-Dihydroquinazolinone Compounds as Na
    Sabnis RW
    ACS Med Chem Lett; 2023 Jul; 14(7):893-894. PubMed ID: 37465303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fused Bicyclic Heteroaryl Compounds as NLRP3 Inhibitors for Treating Asthma or COPD.
    Sabnis RW
    ACS Med Chem Lett; 2023 Jul; 14(7):895-896. PubMed ID: 37465294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Haloacethydrazides as AEP Inhibitors for Treating Alzheimer's Disease.
    Sabnis RW; Sabnis AR
    ACS Med Chem Lett; 2023 Sep; 14(9):1165-1166. PubMed ID: 37736172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Tyrosine Kinase 2 Inhibitors for Treating Autoimmune and Inflammatory Diseases.
    Sabnis RW
    ACS Med Chem Lett; 2024 Jun; 15(6):769-770. PubMed ID: 38894908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protease Inhibitors for Treating or Preventing Coronavirus Infection.
    Sabnis RW
    ACS Med Chem Lett; 2023 Nov; 14(11):1489-1490. PubMed ID: 37974953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Boron-Containing Pyrazole Compounds as JAK Inhibitors for Treating Inflammation, Autoimmune Diseases, and Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2022 Oct; 13(10):1554-1555. PubMed ID: 36267133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Myeloperoxidase Inhibitors for Treating Multiple Diseases.
    Sabnis RW
    ACS Med Chem Lett; 2024 May; 15(5):569-570. PubMed ID: 38746891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TYK2 Inhibitors for Treating Autoimmune and Inflammatory Diseases.
    Sabnis RW
    ACS Med Chem Lett; 2024 Mar; 15(3):320-321. PubMed ID: 38505839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel KRAS Inhibitors for Treating Non-Small-Cell Lung Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2024 Jun; 15(6):773-774. PubMed ID: 38894899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel KRAS Inhibitors for Treating Non-small Cell Lung Cancer.
    Sabnis RW
    ACS Med Chem Lett; 2024 Aug; 15(8):1201-1202. PubMed ID: 39140050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.